行情

NNVC

NNVC

NANOVIRICIDES
AMEX
1.640
-0.010
-0.61%
已收盘, 16:00 11/29 EST
开盘
1.610
昨收
1.650
最高
1.666
最低
1.600
成交量
2.67万
成交额
3.32万
52周最高
4.900
52周最低
1.040
市值
1,904.04万
市盈率(TTM)
-2.6819
分时
5日
1月
3月
1年
5年
NanoViricides 预计将有足够的资金来完成 COVID-19 候选药物的人体试验
NanoViricides 预计将有足够的资金来完成 COVID-19 候选药物的人体试验
MT Newswires · 10/14 07:50
美股异动 | 抗疫概念股普跌 诺瓦瓦克斯(NVAX.US)跌超5%
8月17日(周三)美股盘初,截至发稿,美国抗疫概念股普跌。
智通财经 · 08/17 14:09
NNVC 简况
NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is engaged in discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. The nanomedicines technology also enables attacking the rapid intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company is developing antiviral drug candidate, NV-CoV-2 drug for the treatment of COVID-19 infected sick persons. Its other clinical drug candidate NV-HHV-101 a skin cream for the treatment of shingles rash. The Company also offers several additional pre-clinical drug development programs, including Herpes Simplex Viruses (HSV-1 that causes cold sores, and HSV-2 that causes genital ulcers), HIV/AIDS, Influenza, Dengue viruses, and Ebola/Marburg.

微牛提供NanoViricides Inc(AMEX-NNVC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NNVC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NNVC股票基本功能。